An atlas of genetic influences on human blood metabolites

Shin et al., Nature Genetics, 2014 [ Article | SI Text ]

Locus 1: ALPL (1p36.12)

Meta-analysis summary statistics for associations meeting genome-wide significance
Lead SNPBiochemicalsEA/OANtotalEAFEffect (SE)PmetaDetails
rs1697421 DSGEGDFXAEGGGVR* / ADpSGEGDFXAEGGGVR* T/C 3777 0.52 -0.056 (0.006) 1.56·10-20 show
rs1697421 ADSGEGDFXAEGGGVR* / ADpSGEGDFXAEGGGVR* T/C 3788 0.52 -0.042 (0.006) 3.38·10-14 show

EA = effect allele; OA = other allele; EAF = frequency of effect allele;

Summary of biological annotations
SNPrs1697421
Chromosomal locationChr1: 21,695,879 (1p36.12)
Gene (distance)ALPL (-12,565)
Predicted causal geneALPL
Gene/protein classification-
Metabolite (Pathway)DSGEGDFXAEGGGVR* (Fibrinogen cleavage peptide; Peptide)
ADpSGEGDFXAEGGGVR* (Fibrinogen cleavage peptide; Peptide)
Biochemical locus-metabolite relationshipALPL encodes a phosphatase, which could possibly have a bearing on the phosphorylation state of fibrinogen. The alpha chain of fibrinogen is known to be phosphorylated at Ser22 [16807684]. Ratio interpretation: indicates likely substrate/product pair ('activity'). ALPL plausibly affects phosphorylation state of fibrinogen
eQTL associationsALPL (S) †

† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;

Medical information
Complex trait associationsPhosphorus levels [20558539]
Known metabolite associationsADpSGEGDFXAEGGGVR*/DSGEGDFXAEGGGVR* [21886157] (r2=0.665 with rs10799701)
Inborn error of metabolism-

Pharmacological information
ChEMBL IDCHEMBL5979
Drug information Approved drugs with activity in ChEMBL

Locus information for top associated metabolite

HapMap2 imputation

Imputation HapMap

1KGP imputation

Imputation 1KGP

 

Network view
Association map